| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6085cc981958ccb9f6c9c0b5ead9f539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e31d5527cc09ceeaf6f794a67e78587b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-206 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
2010-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65e401f871e53bcd3f90a74fe9f1d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_345efd31e8ecd5a6fccf52b86ef20387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63c04db1931eaa724f4a3a99bde07034 |
| publicationDate |
2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI1002331-B1 |
| titleOfInvention |
biocomposite, related uses, process for its production, and method of controlled release of antimicrobial substance |
| abstract |
biocomposite, related uses, process for its production, and method of controlled release of antimicrobial substance. The present invention provides a hydroxyapatite based biocompound ca ~ 10 ~ (po4) ~ 6 ~ (oh) ~ 2 ~ and sodium alginate. the product in the form of beads / microspheres is preferably associated with the chlorhexidine digluconate cationic antimicrobial agent (c ~ 22 ~ h ~ 30 ~ cl ~ 2 ~ n ~ 10 ~ <sym> 2 c ~ 6 ~ h ~ 12 ~ o ~ 7 ~), in order to promote the regeneration of tissue lesions and combat microbial infections by acting as a controlled release vehicle of the substance. |
| priorityDate |
2010-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |